Fact CheckerSign in

NCT07740668Not yet recruiting

Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After Stroke

Source: ClinicalTrials.gov · Last updated 31 Jul 2026

Brief summary (registry, in English)

This study is a prospective, randomized controlled clinical trial designed to evaluate the efficacy of transcutaneous electrical stimulation (posterior tibial nerve stimulation, PTNS) in the treatment of overactive bladder (OAB) developing after stroke. Primary Hypothesis: PTNS therapy will significantly improve OAB symptoms in post-stroke patients compared to standard care/sham stimulation. Primary Outcome Measure: Change from baseline in Overactive Bladder Symptom Score (OABSS) and/or frequency of urgency episodes as assessed after 12 weeks of treatment."

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
4 Feb 2026
Start date
1 Sept 2026
Primary completion date
1 Sept 2027
Lead sponsor
Kutahya Health Sciences University
Diseases
Stroke
NCT number
NCT07740668

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 1 Sept 2026 to the primary completion date, 1 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Active urinary tract infection
  • Neurogenic conditions other than stroke affecting bladder function

Age

  • Age outside the study range

Other

  • Pregnancy or breastfeeding
  • Inability to comply with study procedures
  • Refusal or inability to provide informed consent

Who the study is looking for

  • Female
  • Age 40 to 70 years
  • History of ischemic or hemorrhagic stroke at least 6 months before enrollment
  • Presence of overactive bladder symptoms
  • Ability to provide written informed consent

Age in the registry: 40 years to 70 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kütahya Health Sciences University
Coordinator of this site? Confirm its status
KütahyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.